All Stories

  1. PD-L1 expression as biomarker of efficacy of PD-1/PD-L1 checkpoint inhibitors in metastatic triple negative breast cancer: A systematic review and meta-analysis

    Article • Frontiers in Immunology, March 2023, Frontiers

    Dr Muhammad Khan

  2. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective

    Article • Frontiers in Immunology, December 2022, Frontiers

    Dr Muhammad Khan

  3. A novel necroptosis-related gene index for predicting prognosis and a cold tumor immune microenvironment in stomach adenocarcinoma

    Article • Frontiers in Immunology, October 2022, Frontiers

    Dr Muhammad Khan

  4. Berberine Attenuates Cell Motility via Inhibiting Inflammation-Mediated Lysyl Hydroxylase-2 and Glycolysis

    Article • Frontiers in Pharmacology, April 2022, Frontiers

    Dr Muhammad Khan

  5. Anti-PD1 Therapy Plus Whole-Brain Radiation Therapy May Prolong PFS in Selected Non–Small Cell Lung Cancer Patients with Brain Metastases: A Retrospective Study

    Article • International Journal of General Medicine, November 2021, Taylor & Francis

    Dr Muhammad Khan

  6. Efficacy and Safety of Actively Personalized Neoantigen Vaccination in the Management of Newly Diagnosed Glioblastoma: A Systematic Review

    Article • International Journal of General Medicine, September 2021, Taylor & Francis

    Dr Muhammad Khan

  7. Impact of Tyrosine Kinase Inhibitors (TKIs) Combined With Radiation Therapy for the Management of Brain Metastases From Renal Cell Carcinoma

    Article • Frontiers in Oncology, July 2020, Frontiers

    Dr Muhammad Khan

  8. Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases

    Article • Frontiers in Oncology, July 2020, Frontiers

    Dr Muhammad Khan

  9. NK Cell-Based Immune Checkpoint Inhibition

    Article • Frontiers in Immunology, February 2020, Frontiers

    Dr Muhammad Khan

  10. Comparative analysis of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer in terms of their long-term oncological outcomes: a meta-analysis of 3410 gastric cancer patients

    Article • World Journal of Surgical Oncology, May 2019, Springer Science + Business Media

    Dr Muhammad Khan

  11. Silencing UBE4B induces nasopharyngeal carcinoma apoptosis through the activation of caspase3 and p53

    Article • OncoTargets and Therapy, April 2019, Dove Medical Press

    Dr Muhammad Khan

  12. Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors

    Article • Frontiers in Oncology, March 2019, Frontiers

    Dr Muhammad Khan

  13. ALK Inhibitors in the Treatment of ALK Positive NSCLC

    Article • Frontiers in Oncology, January 2019, Frontiers

    Dr Muhammad Khan

  14. Interleukin-6 Gene Promoter Region Polymorphism in Patients with Dilated Cardiomyopathy

    Article • Cardiology and Cardiovascular Medicine, January 2019, Fortune Journals

    Dr Muhammad Khan

  15. Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer

    Article • Medicine, August 2018, Wolters Kluwer Health

    Dr Muhammad Khan

  16. SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases

    Article • Technology in Cancer Research & Treatment, January 2018, SAGE Publications

    Dr Muhammad Khan

  17. Comparison of WBRT alone, SRS alone, and their combination in the treatment of one or more brain metastases: Review and meta-analysis

    Article • Tumor Biology, July 2017, SAGE Publications

    Dr Muhammad Khan